MKI67 and breast neoplasm: The goal of the current analysis is to replicate the results of the prior two window-of-opportunity studies [41,43] and to evaluate the impact of a short-term oral, high-potency statin on changes in expression of predictive markers of breast tumor proliferation (Ki-67 and cyclin D1) and markers of apoptosis (CC3) and cell cycle arrest (p27).